Aidoc vs Gleamer (2026)
A platform against a specialist. Aidoc runs detection models across an imaging estate through an operating system that handles normalization, continuous monitoring and governance, with a 2026 clearance covering many acute indications from one named foundation model. Gleamer does trauma radiography, with a fracture detection clearance that covers both adult and pediatric use. If your department needs one specific reading improved, particularly the overnight trauma queue, Gleamer is the sharper instrument and reaches you through several platforms. If you expect to run clinical AI across modalities for a decade, Aidoc is selling the layer that survives whichever algorithms you replace.
- It runs many detection models across an imaging estate through an operating system handling normalization, monitoring and governance for every model on it.
- The 2026 clearance covers 11 acute findings on body CT from a single named foundation model, with performance from a regulator reviewed pivotal study.
- For a health system standardizing clinical AI across modalities, the infrastructure is the durable purchase rather than any one algorithm.
- Its fracture detection clearance covers both adult and pediatric use, backed by a fully crossed multiple reader, multiple case study.
- It is aimed at trauma radiographs, a large share of the plain film reading in an emergency department.
- Distribution breadth substitutes for integration engineering, available directly and through several imaging platform partners.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Aidoc and Gleamer are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Aidoc | Gleamer |
|---|---|---|
| Primary category | Radiology & Imaging AI | Radiology & Imaging AI |
| Founded | 2016 | 2017 |
| Headquarters | Tel Aviv, Israel | Saint-Mandé, France |
| Website | aidoc.com | gleamer.ai |
Side by Side
Select any grade to read the note behind it.
Product updates
The latest logged changes from each vendor, newest first, each linked to its source.
Aidoc
-
Regulatory / FDA
Aidoc received FDA Breakthrough Device Designation for CARE Chest X-Ray Triage, built on its CARE foundation model, covering triage of pneumomediastinum and lobar or lung collapse.
Source -
Clinical evidence
Mercy and Aidoc released a white paper, commissioned by AVIA, reporting on five months of AI deployment across the Mercy health system.
Source -
Regulatory / FDA
The FDA cleared Aidoc's comprehensive abdomen CT triage solution, powered by its self developed CARE foundation model, bringing 11 newly cleared indications together with three previously cleared into a single 14 indication workflow.
Source
Each vendor in one paragraph
Written to be quoted whole. Each paragraph opens the AI Health Index profile of the vendor: what the product is, who buys it and what it does.
Aidoc sells clinical AI for imaging triage and follow up to health systems, delivered through aiOS, an enterprise platform that runs Aidoc's own FDA cleared algorithms alongside vetted partner algorithms and carries care coordination and patient management. Aidoc Medical was established in early 2016 in Tel Aviv and is led by cofounder and chief executive Elad Walach.
Source: AI Health Index, August 2026
Gleamer SAS is a radiology AI company based in Saint-Mandé, on the edge of Paris, and since 2 March 2026 part of DeepHealth, the digital health subsidiary of the US imaging services operator RadNet, Inc. RadNet announced the all cash acquisition at up to 230 million euros, about 215 million at closing plus a 15 million contingent milestone. Gleamer's site and products keep the Gleamer name.
Source: AI Health Index, August 2026
Questions buyers ask
How do Aidoc and Gleamer work with the EHR?
Aidoc ingests DICOM routed or queried from PACS and VNA or sent from modalities, plus HL7 messages, and returns results to a desktop widget, the native worklist, the reporting system, or PACS as a separate series. Authentication runs through Active Directory, a dedicated single sign on, or sign on through PACS, RIS or dictation software, a practical detail in a radiology department.
Gleamer has been part of DeepHealth, the digital health subsidiary of RadNet, since March 2026, and nothing published says whether the products now run inside DeepHealth's platform or remain available on other vendors' archives. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified August 4, 2026. No vendor pays for placement.
How are Aidoc and Gleamer priced and sold?
Aidoc sells aiOS and its cleared modules to health systems under enterprise agreements through a demo, and maintains an AWS Marketplace listing, which makes the procurement channel public; the listing states that pricing depends on the duration and terms of the contract agreed with the vendor. Whether pricing runs per module, per study volume or per site, and how partner algorithms on aiOS are billed, is not stated.
For Gleamer, the packaging and the owner are public. The products are sold as modules of the Gleamer Copilot suite, and since March 2026 Gleamer has been part of DeepHealth, the digital health subsidiary of RadNet, so contracting may run through DeepHealth. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified August 4, 2026. No vendor pays for placement.
How do Aidoc and Gleamer handle patient data?
With Aidoc, the company's security and privacy documentation describes a new DICOM object created before upload carrying only non PHI data and a newly generated identifier; analysis runs on that object, and the identifier re-attaches PHI locally when results return.
When Gleamer receives patient data from a customer, including imaging examinations and reports, it acts as the customer's processor and works on pseudonymized data, and where the customer authorizes it, Gleamer may anonymize pseudonymized patient data and use the anonymized result for its own purposes, including training and developing its products. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified August 4, 2026. No vendor pays for placement.
Which settings and specialties do Aidoc and Gleamer cover?
For Aidoc, the company reports use in more than 1,600 medical centers and names health systems including WellSpan, Mercy, Yale New Haven, St. Luke's and Renown. Validation sits at the level of each cleared indication, with its own FDA review, and the research library is organized by condition.
With Gleamer, the suite now claims far wider coverage, described by the company as covering all imaging modalities, with products for chest X-ray, chest CT, bone CT, breast imaging, brain MRI and lumbar spine MRI. Validation for those is not summarized on the home page, and ChestView and BoneMetrics have their own FDA summaries. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified August 4, 2026. No vendor pays for placement.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers.
The comparison is between a platform and a point solution, so the honest question is whether you are buying infrastructure or a specific reading. Gleamer's distribution through several partners makes data stewardship harder to pin down, since it publishes no business associate terms, the responsible party varies by delivery path, and it publishes no security attestation. Neither publishes a subgroup performance analysis, and prevalence in your own population determines the false positive burden more than published sensitivity does.